SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OZON- Cyclopss
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Stewart who wrote (89)4/11/1997 5:36:00 PM
From: Glass House   of 202
 
Marlin, Good question but I would tend to view this as positive news. In the past OZON has had tons of vision but too little actual sales. This has probably been from not enough management to attend to details. Plus, this is the one area of the company that had actual sales, which means they have some money to justify some help.

Another, not totally unrelated thought is that I prefer their approach the last few months of making PR releases but not overly hyping the stock. They have desperately needed real sales which are finally starting to happen. This will help them slowly build a base. They had lost their "story stock" status some time ago and it would not be good to build another "story" until they have some real sales and hopefully not too far away, some actual profits. Just my current thoughts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News